Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study-Reference-Cited by-同舟云学术

Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study

Published:2016-09-28 Issue:11 Volume:29 Page:1226-1236
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Dharnidharka Vikas R.¹^ORCID,Schnitzler Mark A.²,Chen Jiajing²,Brennan Daniel C.¹,Axelrod David³,Segev Dorry L.⁴,Schechtman Kenneth B.¹,Zheng Jie¹,Lentine Krista L.²

Affiliation:

1. Washington University in St. Louis School of Medicine; Saint Louis MO USA

2. Saint Louis University School of Medicine; Saint Louis MO USA

3. Eastern Carolina University; Greeneville NC USA

4. Johns Hopkins University; Baltimore MD USA

Funder

National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12850/fullpdf

Reference44 articles.

1. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group;Nashan;Lancet,1997

2. Cyclosporine: five years' experience in cadaveric renal transplantation;Merion;N Engl J Med,1984

3. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group;Lancet,1995

4. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group;Transplantation,1996

5. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group;Kahan;Lancet,2000

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney transplantation: the recipient;Living Donor Organ Transplantation;2024

2. Immune tolerance via FCR001 cell therapy compared with maintenance immunosuppression for kidney transplantation: Real‐world evidence analysis of safety and efficacy;Clinical Transplantation;2023-08-03

3. Visual evoked potentials as a method for the prospective assessment of tacrolimus neurotoxicity in patients after kidney transplantation;Documenta Ophthalmologica;2022-10-26

4. Impact of CYP3A5 Status on the Clinical and Financial Outcomes Among African American Kidney Transplant Recipients;Transplantation Direct;2022-09-15

5. Management of Hospitalized Kidney Transplant Recipients for Hospitalists and Internists;The American Journal of Medicine;2022-08